Two UC San Diego Researchers Receive NIH High-Risk, High-Reward Awards
Two University of California San Diego researchers have received prestigious awards through the 2020 National Institutes of Health (NIH) High-Risk, High-Reward Research Program.
Health & Behavior
The Latest
Personalized Cancer Therapy Improves Outcomes in Advanced Disease, Says Study
Patients receiving care for advanced cancer at Moores Cancer Center at UC San Diego Health were more likely to survive or experience a longer period without their disease progressing if they received personalized cancer therapy.
Vice Chancellor for Research Sandra A. Brown Receives Two Prestigious Research Awards
UC San Diego Vice Chancellor for Research Sandra A. Brown has received two national recognitions for her pioneering research in the field of psychology from the APA and the NIAAA.
UC San Diego Health Joins International Clinical Trial to Test Coronavirus Vaccine
UC San Diego Health will be a test site for a third, major Phase III clinical trial to assess a vaccine candidate for the novel coronavirus that causes COVID-19. Sponsored by Janssen Pharmaceuticals, the trial will recruit up to 60,000 participants at sites in the United States and worldwide.
UC San Diego Partners with San Ysidro Health to Expand COVID-19 Testing
Researchers at University of California San Diego School of Medicine, in collaboration with local partners, have been awarded a $5 million grant from the National Institutes of Health (NIH) to implement a program of widespread testing for COVID-19 in San Ysidro.
UC San Diego COVID-19 Forecast Now Part of CDC Model
A computational model that forecasts the number of COVID-19 deaths in the United States as a whole and in each state developed by a team of researchers from UC San Diego and Northeastern University is now part of the national mortality forecast issued by the Centers for Disease Control.
Stay in the Know
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
